Drug · DIN 02219018
MERREM
ADD-VANTAGE VIALS
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since August 16, 2018.
- Drug Identification Number (DIN)
- 02219018
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Meropenem J01DH02
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| MEROPENEM | 500 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 11, 2018: NOC 20852New Drug Submission (NDS) · Change in product ownership
- July 2, 1996: NOC 6519New Drug Submission (NDS)
Other DINs named MERREM
- DIN 02218488 · Cancelled Post Market
- DIN 02218496 · Cancelled Post Market
- DIN 02219026 · Cancelled Pre Market